TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named June 15, 1990
TCL Archive Patient Advocacy: MBCC Conference Issues Statement On Equal Status On Advocates April 4, 1997
TCL Archive In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam August 30, 1991